Loading clinical trials...
Loading clinical trials...
This study will compare the safety and efficacy of the 700 ug dexamethasone intravitreal implant with ranibizumab 0.5 mg intravitreal injections in patients with diabetic macular edema (DME).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT07425522 · Diabetic Macular Edema
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
NCT07449936 · Diabetic Macular Edema, DME, and more
NCT07362927 · Diabetic Macular Edema (DME)
NCT07449923 · Diabetic Macular Edema, DME, and more
Arlington, Texas
Brussels
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions